Der Nervenarzt · 2026
[Inpatient treatment of substance use disorders : Structures and treatment strategies: results of a nationwide survey of treatment facilities].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Roy Mandy, Deen Aljosha, Porsch Jason, Bader Daniel, Schöneberger Stefan, Strate Peter
Аннотация
BACKGROUND: Systematic data on the implementation of key elements of inpatient treatment for substance use disorders in Germany are still limited.
OBJECTIVE: To systematically assess inpatient care practices with a focus on pharmacological strategies, relapse management, temporal aspects of (qualified) withdrawal treatment, and the management of psychiatric comorbidities, as well as differences between acute care and rehabilitation settings and regional variations.
MATERIALS AND METHODS: Nationwide, anonymized online survey of 500 inpatient facilities (acute care and rehabilitation clinics). Structural characteristics, treatment strategies, and organizational aspects were assessed. Data were analyzed descriptively and inferentially (χ2 test/Fisher's exact test).
RESULTS: A total of 112 facilities participated (68 acute care and 44 rehabilitation clinics). Treatment services covered a broad range of substances. Evidence-based pharmacotherapy for alcohol-related disorders was often not initiated or continued, particularly in rehabilitation settings. Access for patients receiving opioid substitution treatment was limited in these settings. Relapses were frequently managed on an individualized and motivation-based basis; however, in cases of repeated unreported relapse, treatment was often terminated. Temporal aspects of qualified withdrawal treatment varied considerably, with regional differences. Psychiatric comorbidities were widely addressed.
CONCLUSION: Care practices are heterogeneous, with relevant deviations from evidence-based recommendations, particularly regarding pharmacological strategies and access for specific patient groups. There is a need for more consistently evidence-based and patient-centered inpatient treatment approaches.
OBJECTIVE: To systematically assess inpatient care practices with a focus on pharmacological strategies, relapse management, temporal aspects of (qualified) withdrawal treatment, and the management of psychiatric comorbidities, as well as differences between acute care and rehabilitation settings and regional variations.
MATERIALS AND METHODS: Nationwide, anonymized online survey of 500 inpatient facilities (acute care and rehabilitation clinics). Structural characteristics, treatment strategies, and organizational aspects were assessed. Data were analyzed descriptively and inferentially (χ2 test/Fisher's exact test).
RESULTS: A total of 112 facilities participated (68 acute care and 44 rehabilitation clinics). Treatment services covered a broad range of substances. Evidence-based pharmacotherapy for alcohol-related disorders was often not initiated or continued, particularly in rehabilitation settings. Access for patients receiving opioid substitution treatment was limited in these settings. Relapses were frequently managed on an individualized and motivation-based basis; however, in cases of repeated unreported relapse, treatment was often terminated. Temporal aspects of qualified withdrawal treatment varied considerably, with regional differences. Psychiatric comorbidities were widely addressed.
CONCLUSION: Care practices are heterogeneous, with relevant deviations from evidence-based recommendations, particularly regarding pharmacological strategies and access for specific patient groups. There is a need for more consistently evidence-based and patient-centered inpatient treatment approaches.